124 related articles for article (PubMed ID: 14643300)
1. Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles.
Denis-Mize KS; Dupuis M; Singh M; Woo C; Ugozzoli M; O'Hagan DT; Donnelly JJ; Ott G; McDonald DM
Cell Immunol; 2003 Sep; 225(1):12-20. PubMed ID: 14643300
[TBL] [Abstract][Full Text] [Related]
2. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.
Denis-Mize KS; Dupuis M; MacKichan ML; Singh M; Doe B; O'Hagan D; Ulmer JB; Donnelly JJ; McDonald DM; Ott G
Gene Ther; 2000 Dec; 7(24):2105-12. PubMed ID: 11223992
[TBL] [Abstract][Full Text] [Related]
3. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines.
O'Hagan D; Singh M; Ugozzoli M; Wild C; Barnett S; Chen M; Schaefer M; Doe B; Otten GR; Ulmer JB
J Virol; 2001 Oct; 75(19):9037-43. PubMed ID: 11533167
[TBL] [Abstract][Full Text] [Related]
4. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.
zur Megede J; Chen MC; Doe B; Schaefer M; Greer CE; Selby M; Otten GR; Barnett SW
J Virol; 2000 Mar; 74(6):2628-35. PubMed ID: 10684277
[TBL] [Abstract][Full Text] [Related]
5. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.
Dupuis M; Denis-Mize K; Woo C; Goldbeck C; Selby MJ; Chen M; Otten GR; Ulmer JB; Donnelly JJ; Ott G; McDonald DM
J Immunol; 2000 Sep; 165(5):2850-8. PubMed ID: 10946318
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
7. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
8. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.
zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW
J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276
[TBL] [Abstract][Full Text] [Related]
9. In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization.
Barbon CM; Baker L; Lajoie C; Ramstedt U; Hedley ML; Luby TM
Vaccine; 2010 Nov; 28(50):7852-64. PubMed ID: 20943208
[TBL] [Abstract][Full Text] [Related]
10. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.
Deml L; Bojak A; Steck S; Graf M; Wild J; Schirmbeck R; Wolf H; Wagner R
J Virol; 2001 Nov; 75(22):10991-1001. PubMed ID: 11602739
[TBL] [Abstract][Full Text] [Related]
11. Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems.
Singh M; Kazzaz J; Ugozzoli M; Malyala P; Chesko J; O'Hagan DT
Curr Drug Deliv; 2006 Jan; 3(1):115-20. PubMed ID: 16472100
[TBL] [Abstract][Full Text] [Related]
12. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity.
Singh M; Vajdy M; Gardner J; Briones M; O'Hagan D
Vaccine; 2001 Nov; 20(3-4):594-602. PubMed ID: 11672926
[TBL] [Abstract][Full Text] [Related]
14. A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA.
Singh M; Fang JH; Kazzaz J; Ugozzoli M; Chesko J; Malyala P; Dhaliwal R; Wei R; Hora M; O'Hagan D
Int J Pharm; 2006 Dec; 327(1-2):1-5. PubMed ID: 16962267
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles.
Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M
Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793
[TBL] [Abstract][Full Text] [Related]
16. Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.
Marsac D; Loirat D; Petit C; Schwartz O; Michel ML
J Virol; 2002 Aug; 76(15):7544-53. PubMed ID: 12097567
[TBL] [Abstract][Full Text] [Related]
17. The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance.
Singh M; Ugozzoli M; Briones M; Kazzaz J; Soenawan E; O'Hagan DT
Pharm Res; 2003 Feb; 20(2):247-51. PubMed ID: 12636163
[TBL] [Abstract][Full Text] [Related]
18. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine.
Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K
AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091
[TBL] [Abstract][Full Text] [Related]
19. Immunization of neonatal mice with LAMP/p55 HIV gag DNA elicits robust immune responses that last to adulthood.
Rigato PO; Maciel M; Goldoni AL; Piubelli O; de Brito CA; Fusaro AE; Eurico de Alencar LX; August T; Azevedo Marques ET; da Silva Duarte AJ; Sato MN
Virology; 2010 Oct; 406(1):37-47. PubMed ID: 20667577
[TBL] [Abstract][Full Text] [Related]
20. Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector.
Jiang W; Jin N; Cui S; Li Z; Zhang L; Wang H; Han W
J Virol Methods; 2006 Sep; 136(1-2):1-7. PubMed ID: 16793146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
